Finally, disruption of MBNL1-poly(CUG) RNA complexes with either morpholino-oligonucleotides or small molecules is sufficient to reverse pathological findings in DM1 mouse (25) or cell (40) models. This evidence concerns the gene MBNL1 and myotonic dystrophy type 1.